Literature DB >> 9211364

Recurrent corneal erosion associated with Alport's syndrome. Rapid communication.

C Rhys1, B Snyers, Y Pirson.   

Abstract

Ocular defects associated with Alport syndrome (AS) include anterior lenticonus and retinal flecks. We report on recurrent corneal erosion (RCE) as another ocular manifestation of the disease. Three brothers with AS reported a history of spontaneous attacks of RCE (2 episodes over 1 to 3 years in 2 of them and about 60 episodes in one brother over the last 10 years) characterized by acute ocular pain, lacrimation and photophobia lasting two to five days. The absence of RCE in the two other non-affected brothers from the same kindred suggested an association between AS and RCE, and prompted us to assess its prevalence. Forty-one patients with AS and renal failure and 67 control transplanted patients (with another original nephropathy) were evaluated. Seven AS patients had a history of RCE (first manifested between the ages of 12 and 21) versus only one control patient (P = 0.003). In conclusion, a history of RCE is found in about 20% of patients with AS and renal failure. RCE is likely to result from an inherent structural weakness of the corneal epithelial basement membrane (containing type IV collagen). A history of RCE should be sought when evaluating a patient for AS. Ophthalmologists should also be aware of this association, when confronted with a patient suffering from non-traumatic RCE.

Entities:  

Mesh:

Year:  1997        PMID: 9211364     DOI: 10.1038/ki.1997.321

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

Review 1.  Ocular features in Alport syndrome: pathogenesis and clinical significance.

Authors:  Judy Savige; Shivanand Sheth; Anita Leys; Anjali Nicholson; Heather G Mack; Deb Colville
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

2.  A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.

Authors:  Asli Subasioglu Uzak; Bulent Tokgoz; Munis Dundar; Mustafa Tekin
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-08

3.  Renal, auricular, and ocular outcomes of Alport syndrome and their current management.

Authors:  Yanqin Zhang; Jie Ding
Journal:  Pediatr Nephrol       Date:  2017-09-01       Impact factor: 3.714

Review 4.  Familial hematurias: what we know and what we don't.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

Review 5.  Familial hematuria.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2007-10-02       Impact factor: 3.714

Review 6.  Opinion: Ocular features aid the diagnosis of Alport syndrome.

Authors:  Judy Savige; Deb Colville
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314

7.  Maculopathy, Fundus Changes and Anterior Lenticonus in Alport Syndrome.

Authors:  Mirko Ratkovic; Ajla Pidro; Aida Pidro
Journal:  Beyoglu Eye J       Date:  2021-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.